Manganese in children with attention-deficit/hyperactivity disorder: Relationship with methylphenidate exposure

Journal of Child and Adolescent Psychopharmacology

Volumn 20, Issue 2, 2010, Pages 113-118

  Farias, Antonio C ^a,b,c   Cunha, Alexandre ^a,b   Benko, Cássia R ^a,b,d   McCracken, James T ^e   Costa, Maria T ^a   Farias, Lucilene G ^a,b   Cordeiro, Mara L ^a,b,e  

^a Research Institute Pelé Pequeno Príncipe   (Brazil)

^b INSTITUTO DE PESQUISA PELÉ PEQUENO PRÍNCIPE   (Brazil)

^c Children's Hospital Pequeno Príncipe   (Germany)

^d HOSPITAL PEQUENO PRÍNCIPE   (Brazil)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; DOPAMINE TRANSPORTER; MANGANESE; METHYLPHENIDATE; PSYCHOSTIMULANT AGENT;

ARTICLE; ATTENTION DEFICIT DISORDER; BLOOD LEVEL; CHILD; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DRUG EXPOSURE; FEMALE; HUMAN; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; DOPAMINE UPTAKE INHIBITORS; ENVIRONMENTAL EXPOSURE; FEMALE; FOOD CONTAMINATION; HUMANS; MALE; MANGANESE; METHYLPHENIDATE;

EID: 77951679067     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2009.0073     Document Type: Article

References (64)

1. Achenbach T: Empirically based taxonomy: How to use syndromes and profile types derived from the CBCL from 4 to 18 TRF and WSR. Burlington (Vermont): University of Vermont Department of Psychiatry; 1993.
2. th edition (DSM-IV). Washington (DC): American Psychiatric Association, 1994.
3. Anderson JG, Cooney PT, Erikson KM: Inhibition of DAT function attenuates manganese accumulation in the globus pallidus. Environ Toxicol Pharmacol 23:179-184, 2007.
4. Aschner M, Guilarte TR, Schneider JS, Zheng W: Manganese: Recent advances in understanding its transport and neurotoxicity. Toxicol Appl Pharmacol 221:131-147, 2007.
5. Banta RG, Markesbery WR: Elevated manganese levels associated with dementia and extrapyramidal signs. Neurology 27:213-216, 1977.
6. Barlow PJ: A pilot study on the metal levels in the hair of hyperactive children. Med Hypotheses. 11:309-318, 1983.
7. Biederman J. Attention-deficit=hyperactivity disorder: A selective overview. Biol Psychiatry 57:1215-1220, 2005.
8. Bird ED, Anton AH, Bullock B: The effect of manganese inhalation on basal ganglia dopamine concentrations in rhesus monkey. Neurotoxicology 5:59-65, 1984.
9. Bouchard M, Laforest F, Vandelac L, Bellinger D, Mergler D: Hair manganese and hyperactive behaviors: Pilot study of school-age children exposed through tap water. Environ Health Perspect 115:122-127, 2007.
10. Bowler RM, Koller W, Schulz PE: Parkinsonism due to manganism in a welder: Neurological and neuropsychological sequelae. Neuro-toxicology 27:327-332, 2006.
11. Calne DB, Chu NS, Huang CC, Lu CS, Olanow W: Manganism and idiopathic parkinsonism: Similarities and differences. Neurology 44:1583-1586, 1994.
12. Cersosimo MG, Koller WC: The diagnosis of manganese-induced parkinsonism. Neurotoxicology 27:340-346, 2006.
13. Chen JY, Tsao GC, Zhao Q, Zheng W: Differential cytotoxicity of Mn(II) and Mn(III): Special reference to mitochondrial [Fe-S] containing enzymes. Toxicol Appl Pharmacol 175:160-168, 2001.
14. Chen MK, Lee JS, McGlothan JL, Furukawa E, Adams RJ, Alexander M, Wong DF, Guilarte TR: Acute manganese administration alters dopamine transporter levels in the non-human primate striatum. Neurotoxicology 27:229-236, 2006.
15. Cockell KA, Bonacci G, Belonje B: Manganese content of soy or rice beverages is high in comparison to infant formulas. J Am Coll Nutr 23:124-130, 2004.
16. Collipp PJ, Chen SY, Maitinsky S: Manganese in infant formulas and learning disability. Ann Nutr Metab 27:488-494, 1983.
17. Conners C: The Conners' Rating Scale: Instruments for the Assessments of Childhood Psychopathology. Durham (North Carolina): Duke University, 1995.
18. Dietz MC, Ihrig A, Wrazidlo W, Bader M, Jansen O, Triebig G: Results of magnetic resonance imaging in long-term manganese dioxide-exposed workers. Environ Res 85:37-40, 2001.
19. Dobson AW, Erikson KM, Aschner M: Manganese neurotoxicity. Ann NY Acad Sci 1012:115-128, 2004.
20. Erikson KM, Aschner M: Increased manganese uptake by primary astrocyte cultures with altered iron status is mediated primarily by divalent metal transporter. Neurotoxicology 27:125-130, 2006.
21. Faraone SV, Doyle AE: The nature and heritability of attention-deficit= hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 10:299-316, viii-ix, 2001.
22. Golub MS, Hogrefe CE, Germann SL, Tran TT, Beard JL, Crinella FM, Lonnerdal B: Neurobehavioral evaluation of rhesus monkey infants fed cow's milk formula, soy formula, or soy formula with added manganese. Neurotoxicol Teratol 27:615-627, 2005.
23. Guilarte TR, Chen MK, McGlothan JL, Verina T, Wong DF, Zhou Y, Alexander M, Rohde CA, Syversen T, Decamp E, Koser AJ, Fritz S, Gonczi H, Anderson DW, Schneider JS: Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates. Exp Neurol 202:381-390, 2006.
24. Guilarte TR, Burton NC, McGlothan JL, Verina T, Zhou Y, Alexander M, Pham L, Griswold M, Wong DF, Syversen T, Schneider JS: Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): Implications to manganese-induced parkinsonism. J Neurochem 107:1236-1247, 2008.
25. He P, Liu DH, Zhang GQ: [Effects of high-level-manganese sewage irrigation on children's neurobehavior]. Zhonghua Yu Fang Yi Xue Za Zhi 28:216-218, 1994.
26. Huang CC, Weng YH, Lu CS, Chu NS, Yen TC: Dopamine transporter binding in chronic manganese intoxication. J Neurol 250: 1335-1339, 2003.
27. Ingersoll RT, Montgomery EB Jr, Aposhian HV: Central nervous system toxicity of manganese. II: Cocaine or reserpine inhibit manganese concentration in the rat brain. Neurotoxicology 20:467-476, 1999.
28. Iregren A: Psychological test performance in foundry workers exposed to low levels of manganese. Neurotoxicol Teratol 12:673-675, 1990.
29. Josephs KA, Ahlskog JE, Klos KJ, Kumar N, Fealey RD, Trenerry MR, Cowl CT: Neurologic manifestations in welders with pallidal MRI T1 hyperintensity. Neurology 64:2033-2039, 2005.
30. Klos KJ, Ahlskog JE, Kumar N, Cambern S, Butz J, Burritt M, Fealey RD, Cowl CT, Parisi JE, Josephs KA: Brain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensity. Neurology 67:1984-1989, 2006.
31. Kuczenski R, Segal DS: Exposure of adolescent rats to oral methyl-phenidate: Preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphet-amine. J Neurosci 22:7264-7271, 2002.
32. Levy F, Hay DA, McStephen M, Wood C, Waldman I: Attention-deficit hyperactivity disorder: A category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry 36:737-744, 1997.
33. Lu CS, Huang CC, Chu NS, Calne DB: Levodopa failure in chronic manganism. Neurology 44:1600-1602, 1994.
34. Lu L, Zhang LL, Li GJ, Guo W, Liang W, Zheng W: Alteration of serum concentrations of manganese, iron, ferritin, and transferrin receptor following exposure to welding fumes among career welders. Neurotoxicology 26:257-265, 2005.
35. Lucchini R, Selis L, Folli D, Apostoli P, Mutti A, Vanoni O, Iregren A, Alessio L: Neurobehavioral effects of manganese in workers from a ferroalloy plant after temporary cessation of exposure. Scand J Work Environ Health 21:143-149, 1995.
36. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M: Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 50:565-576, 1993.
37. McCracken J: Textbook of Pediatric Neuropsychiatry. Washington (DC): American Psychiatric Association Press, 1998.
38. McDougall SA, Reichel CM, Farley CM, Flesher MM, Der-Ghazarian T, Cortez AM, Wacan JJ, Martinez CE, Varela FA, Butt AE, Crawford CA: Postnatal manganese exposure alters dopamine transporter function in adult rats: Potential impact on nonassociative and associative processes. Neuroscience 154:848-860, 2008.
39. Mergler D, Baldwin M: Early manifestations of manganese neuro-toxicity in humans: An update. Environ Res 73:92-100, 1997.
40. Miller AF, Brudvig GW: Electron-transfer events leading to recon-stitution of oxygen-evolution activity in manganese-depleted pho-tosystem II membranes. Biochemistry 29:1385-1392, 1990.
41. Nigg JT, Knottnerus GM, Martel MM, Nikolas M, Cavanagh K, Karmaus W, Rappley MD: Low blood lead levels associated with clinically diagnosed attention-deficit=hyperactivity disorder and mediated by weak cognitive control. Biol Psychiatry 63:325-331, 2008.
42. Pihl RO, Parkes M: Hair element content in learning disabled children. Science 198:204-206, 1977.
43. Rabin O, Hegedus L, Bourre JM, Smith QR: Rapid brain uptake of manganese(II) across the blood-brain barrier. J Neurochem 61:509-517, 1993.
44. Roels H, Sarhan MJ, Hanotiau I, de Fays M, Genet P, Bernard A, Buchet JP, Lauwerys R: Preclinical toxic effects of manganese in workers from a Mn salts and oxides producing plant. Sci Total Environ 42:201-206, 1985.
45. Roels H, Lauwerys R, Buchet JP, Genet P, Sarhan MJ, Hanotiau I, de Fays M, Bernard A, Stanescu D: Epidemiological survey among workers exposed to manganese: Effects on lung, central nervous system, and some biological indices. Am J Ind Med 11:307-327, 1987.
46. Roels HA, Ghyselen P, Buchet JP, Ceulemans E, Lauwerys RR: Assessment of the permissible exposure level to manganese in workers exposed to manganese dioxide dust. Br J Ind Med 49:25-34, 1992.
47. Segal DS, Kuczenski R: An escalating dose "binge" model of amphetamine psychosis: Behavioral and neurochemical characteristics. J Neurosci 17:2551-2566, 1997.
48. Shaffer D, Fisher P, Lucas CP, Dulcan MK, Schwab-Stone ME: NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): Description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry 39:28-38, 2000.
49. Shen XM, Dryhurst G: Iron-and manganese-catalyzed autoxidation of dopamine in the presence of L-cysteine: Possible insights into iron-and manganese-mediated dopaminergic neurotoxicity. Chem Res Toxicol 11:824-837, 1998.
50. Smalley SL: Genetic influences in childhood-onset psychiatric disorders: Autism and attention-deficit=hyperactivity disorder. Am J Hum Genet 60:1276-1282, 1997.
51. Stein LM: Teste de Desempenho Escolar (TDE): Manualde Aplicação e Interpretação [Scholastic Achievement Test: Manual of Administration and Interpretation]. Sao Paulo, Brazil: Casa do Psicologo, 1994.
52. Suarez N, Eriksson H: Receptor-mediated endocytosis of a manganese complex of transferrin into neuroblastoma (SHSY5Y) cells in culture. J Neurochem 61:127-131, 1993.
53. Swanson J: SNAP-IV Teacher and Parent Rating Scale. Irvine (California): University of California Irvine Child Development Center, 1995.
54. Swanson J, Castellanos FX, Murias M, LaHoste G, Kennedy J: Cognitive neuroscience of attention deficit hyperactivity disorder and hyperkinetic disorder. Curr Opin Neurobiol 8:263-271, 1998.
55. Swanson JM, Kinsbourne M, Nigg J, Lanphear B, Stefanatos GA, Volkow N, Taylor E, Casey BJ, Castellanos FX, Wadhwa PD: Etiologic subtypes of attention-deficit=hyperactivity disorder: Brain imaging, molecular genetic and environmental factors and the do-pamine hypothesis. Neuropsychol Rev 17:39-59, 2007.
56. Thapar A, Holmes J, Poulton K, Harrington R: Genetic basis of attention deficit and hyperactivity. Br J Psychiatry 174:105-111, 1999.
57. Tran TT, Chowanadisai W, Crinella FM, Chicz-DeMet A, Lonnerdal B: Effect of high dietary manganese intake of neonatal rats on tissue mineral accumulation, striatal dopamine levels, and neuro-developmental status. Neurotoxicology 23:635-643, 2002.
58. Uchino A, Noguchi T, Nomiyama K, Takase Y, Nakazono T, Nojiri J, Kudo S: Manganese accumulation in the brain: MR imaging. Neuroradiology 49:715-720, 2007.
59. Volkow ND, Wang GJ, Fowler JS, Logan J, Franceschi D, Maynard L, Ding YS, Gatley SJ, Gifford A, Zhu W, Swanson JM: Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: Therapeutic implications. Synapse 43:181-187, 2002.
60. Wasserman GA, Liu X, Parvez F, Ahsan H, Levy D, Factor-Litvak P, Kline J, van Geen A, Slavkovich V, LoIacono NJ, Cheng Z, Zheng Y, Graziano JH: Water manganese exposure and children's intellectual function in Araihazar, Bangladesh. Environ Health Perspect 114:124-129, 2006.
61. Weschsler D: Weschsler Intelligence Scale for Children, 3rd ed. San Antonio (Texas): The Psychological Corporation, 1991.
62. Wolraich ML, Hannah JN, Pinnock TY, Baumgaertel A, Brown J: Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry 35:319-324, 1996.
63. Woolf A, Wright R, Amarasiriwardena C, Bellinger D: A child with chronic manganese exposure from drinking water. Environ Health Perspect 110:613-616, 2002.
64. Wright RO, Amarasiriwardena C, Woolf AD, Jim R, Bellinger DC: Neuropsychological correlates of hair arsenic, manganese, and cadmium levels in school-age children residing near a hazardous waste site. Neurotoxicology 27:210-216, 2006.